Learn more about how we are reimagining the world
Apollo Therapeutics Completes $145 million Financing Round to Expand and Advance Portfolio-Based Drug Development
Apollo’s latest raise will help to further develop its pipeline, expand its operations, and build additional collaborations to advance potentially transformative therapeutic treatments across oncology, major inflammatory disorders, and rare diseases. Get a deeper look into how Apollo is planning to bring life-changing medicines to market sooner here.
June 17, 2021
Investing in the World’s Next Frontiers
Reimagined Ventures Founder, CEO, and CIO Alec Litowitz outlines his view on the 6 key areas of opportunity and growth in the coming decades, and the 3 major macro-trends and tailwinds that are driving them. Come learn about how these changes will fundamentally affect and alter every aspect of our lives going forward, and why now more than ever we need to reimagine what our future will look like.
June 01, 2021